Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesDeferasirox pharmacokinetics in patients with adequate vs. inadequate response
Blood, 09/17/09
Chirnomas D et al. – Tens of thousands of transfusion–dependent (e.g., thalassemia) patients worldwide suffer from chronic iron–overload and its potentially fatal complications. The oral iron chelator, deferasirox became commercially available in many countries since 2006. Effective dosing regimens for inadequately responding patients to deferasirox must be determined.
Related Articles
Update on the use of deferasirox in the management of iron overload
Therapeutics and Clinical Risk Management, 11/05/09
Relevance Score: 89%
Deferasirox (Exjade) significantly improves cardiac T2* in heavily iron-overloaded patients with beta-thalassemia major
Annals of Hematology, 10/07/09
Relevance Score: 85%
Effects of Chelators (Deferoxamine, Deferiprone and Deferasirox) on the Growth of Klebsiella Pneumoniae and Aeromonas Hydrophila Isolated from Transfusion-Dependent Thalassemia Patients
Hemoglobin, 10/23/09
Relevance Score: 82%
A New Era in Iron Chelation Therapy: The Design of Optimal, Individually Adjusted Iron Chelation Therapies for the Complete Removal of Iron Overload in Thalassemia and other Chronically Transfused Patients
Hemoglobin, 10/23/09
Relevance Score: 80%
Risk/Benefit Assessment, Advantages Over Other Drugs and Targeting Methods in the Use of Deferiprone as a Pharmaceutical Antioxidant in Iron Loading and Non Iron Loading Conditions
Hemoglobin, 10/23/09
Relevance Score: 80%
Today in Anemia/Polycythemia...keeping you current
Receive free subspecialty "5-minute updates" via email
Hematogones are markedly reduced in pediatric acquired aplastic anemia: multiparametric flow cytometric analysis
Leukemia and Lymphoma, 12/17/09
Red Blood Cell Distribution Width and Risk of Cardiovascular Events and Mortality in a Community Cohort in Taiwan
American Journal of Epidemiology, 12/17/09
Prolonged anemia in an intrauterine-transfused neonate with Rh-hemolytic disease: no evidence for anti-D–related suppression of erythropoiesis in vitro
Transfusion, 12/16/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer
Medical Oncology, 12/17/09
Anti-tumor activity and mechanisms of a novel vascular disrupting agent, (Z)-3,4?,5-trimethoxylstilbene-3?-O-phosphate disodium (M410)
Investigational New Drugs, 12/17/09
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor